Cerebral Venous Thrombosis: Medical Management vs. Endovascular Therapy.

Bibliographic Details
Title: Cerebral Venous Thrombosis: Medical Management vs. Endovascular Therapy.
Authors: Begley, Sabrina L., White, Timothy G., Katz, Jeffrey M.
Source: Current Treatment Options in Neurology; Jun2023, Vol. 25 Issue 6, p169-185, 17p
Abstract: Purpose of review: Cerebral venous thrombosis management has significantly evolved over the past decades. While anticoagulation (AC) use is widely accepted in treating CVT, medication class and dosing paradigm remain unclear. Furthermore, the role of endovascular interventions, including thrombectomy and intrasinus thrombolytics, is undefined. We present a review of recent clinical evidence for treatment and propose areas of future study. Recent findings.: Low molecular weight heparin (LMWH) may be beneficial over standard unfractionated heparin (UFH). While limited randomized trials assessed direct oral AC (DOAC) therapy in CVT, multiple studies, including the recent ACTION-CVT and RESPECT CVT trials, suggest the safety and efficacy of DOACs over warfarin. The role of endovascular therapy remains unclear; however, evidence demonstrates relative safety and potential clinical efficacy in improving recanalization rates. Advancements in endovascular therapy will be in optimizing patient selection and the developing devices tailored to venous sinus thrombectomy. Summary: CVT treatment has significantly progressed. DOACs and endovascular rescue therapy are now utilized for efficient recanalization to minimize sequelae such as hemorrhage, venous infarction, and intracranial hypertension. However, the relative rarity of CVT has led to understudy. Thankfully, international collaborations are creating large, randomized trials and cohort studies to answer numerous outstanding questions. [ABSTRACT FROM AUTHOR]
Copyright of Current Treatment Options in Neurology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:10928480
DOI:10.1007/s11940-023-00752-9
Published in:Current Treatment Options in Neurology
Language:English